Skip to main content

RiaSTAP Side Effects

Generic name: fibrinogen

Medically reviewed by Drugs.com. Last updated on Jul 1, 2024.

Note: This document provides detailed information about RiaSTAP Side Effects associated with fibrinogen. Some dosage forms listed on this page may not apply specifically to the brand name RiaSTAP.

Applies to fibrinogen: intravenous powder for solution.

Serious side effects of RiaSTAP

Along with its needed effects, fibrinogen (the active ingredient contained in RiaSTAP) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking fibrinogen:

More common side effects

  • chest pain
  • dizziness or lightheadedness
  • fever
  • headache
  • nausea
  • numbness or tingling in the hands or feet
  • unusual tiredness or weakness
  • vomiting

Incidence not known

  • anxiety
  • chest discomfort or tightness
  • chills
  • cough
  • difficult or labored breathing
  • difficulty with swallowing
  • fainting
  • fast heartbeat
  • pain or discomfort in the arms, jaw, back, or neck
  • pain, redness, or swelling in the arm or leg
  • pains in the groin or legs, especially in the calves of the legs
  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
  • severe headaches of sudden onset
  • skin rash, hives, or itching
  • sudden loss of coordination
  • sudden onset of slurred speech
  • sudden vision changes
  • sweating
  • trouble breathing

Managing side effects (general information)

For healthcare professionals

Applies to fibrinogen: intravenous powder for injection.

General adverse events

General side effects have included chills, fever, nausea, and vomiting.[Ref]

Hypersensitivity

Hypersensitivity side effects have included allergic-anaphylactic reactions (including rash and dyspnea).[Ref]

Cardiovascular

Cardiovascular side effects have included thromboembolic episodes, including myocardial infarction, pulmonary embolism, deep vein thrombosis, and arterial thrombosis.[Ref]

References

1. (2009) "Product Information. RiaSTAP (fibrinogen)." CSL Behring LLC

Further information

RiaSTAP side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer